http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9511677-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_098acfa7c0c56ef7bd08b7fce9ef16d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5a95d4999542f2d9fa147bfed0e90cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec621571cc75d1a0e873f7603b26d33d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 1994-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9ab3f03395c045e8467f988f0ee33d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84ffb5fc922d0e35b3d5d6c5f9743c40
publicationDate 1995-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9511677-A1
titleOfInvention A stable pharmaceutical composition of terfenadine and ibuprofen
abstract The present invention is directed to a chemically stable pharmaceutical composition containing ibuprofen in combination with terfenadine, wherein the oxidation of terfenadine to terfenadone is prevented by the presence in the composition of an α-hydroxy carboxylic acid.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863287-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1572206-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1572206-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2003301188-B2
priorityDate 1993-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0348683-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9205783-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8808302-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129782593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129157142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129266124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128551545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128530096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129470774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7048803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128007126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519

Total number of triples: 58.